Literature DB >> 20950269

Current approaches for drug delivery to central nervous system.

Sharif Hossain1, Toshihiro Akaike, Ezharul Hoque Chowdhury.   

Abstract

Brain, the center of the nervous system in all vertebrate, plays the most vital role in every function of human body. However, many neurodegenerative diseases, cancer and infections of the brain become more prevalent as populations become older. In spite of the major advances in neuroscience, many potential therapeutics are still unable to reach the central nervous system (CNS) due to the blood-brain barrier (BBB) which is formed by the tight junctions within the capillary endothelium of the vertebrate brain. This results in the capillary wall behaving as a continuous lipid bilayer and preventing the passage of polar and lipid insoluble substances. Several approaches for delivering drugs to the CNS have been developed to enhance the capacity of therapeutic molecules to cross the BBB by modifying the drug itself, or by coupling it to a vector for receptor-mediated, carrier mediated or adsorption-mediated transcytosis. The current challenge is to develop drug delivery systems that ensure the safe and effective passage of drugs across the BBB. This review focuses on the strategies and approaches developed to enhance drug delivery to the CNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20950269     DOI: 10.2174/156720110793566245

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  3 in total

1.  A2A Adenosine Receptor Regulates the Human Blood-Brain Barrier Permeability.

Authors:  Do-Geun Kim; Margaret S Bynoe
Journal:  Mol Neurobiol       Date:  2014-09-28       Impact factor: 5.590

Review 2.  Dysregulation of miRNA and its potential therapeutic application in schizophrenia.

Authors:  Ting Cao; Xue-Chu Zhen
Journal:  CNS Neurosci Ther       Date:  2018-03-12       Impact factor: 5.243

Review 3.  Adenosine receptor signaling: a key to opening the blood-brain door.

Authors:  Margaret S Bynoe; Christophe Viret; Angela Yan; Do-Geun Kim
Journal:  Fluids Barriers CNS       Date:  2015-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.